OMI logo

OMI
Owens & Minor, Inc.

2,704
Mkt Cap
$269.58M
Volume
2.4M
52W High
$15.54
52W Low
$3.27
PE Ratio
-0.20
OMI Fundamentals
Price
$3.49
Prev Close
$3.45
Open
$3.36
50D MA
$4.98
Beta
1.41
Avg. Volume
1.87M
EPS (Annual)
-$4.73
P/B
-0.63
Rev/Employee
$461,244.96
Loading...
Loading...
News
all
press releases
Owens & Minor Reports Third Quarter 2025 Financial Results
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2025. Unless otherwise noted, the results herein reflect the Companys continuing operations...
Business Wire·5d ago
News Placeholder
More News
News Placeholder
CeriBell, Inc. (CBLL) Expected to Beat Earnings Estimates: Should You Buy?
CeriBell, Inc. (CBLL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·8d ago
News Placeholder
Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·13d ago
News Placeholder
Owens & Minor Announces Date and Time Change of Third Quarter 2025 Financial Results and Conference Call
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the third quarter of 2025 on Thursday, October 30, 2025, after trading ends on the New York Stock Exchange. The Company will...
Business Wire·20d ago
News Placeholder
OMI Reshapes Portfolio With $375 Million Sale to Platinum Equity
Owens & Minor sharpens its focus on home-based care with a $375M divestiture to Platinum Equity, unlocking cash, tax benefits, and long-term upside through a retained equity stake.
Zacks·26d ago
News Placeholder
Seeking Clues to Owens & Minor (OMI) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
Get a deeper insight into the potential performance of Owens & Minor (OMI) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
Zacks·3mo ago
News Placeholder
Eli Lilly (LLY) Q2 Earnings and Revenues Surpass Estimates
Lilly (LLY) delivered earnings and revenue surprises of +12.48% and +5.48%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
InfuSystems Holdings, Inc. (INFU) Tops Q2 Earnings Estimates
InfuSystems Holdings (INFU) delivered earnings and revenue surprises of +300.00% and -0.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
ResMed (RMD) Surpasses Q4 Earnings and Revenue Estimates
ResMed (RMD) delivered earnings and revenue surprises of +3.66% and +1.87%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3mo ago
News Placeholder
BofA sees termination of Owens–Rotech deal as surprising but potentially positive
Investing.com -- Bank of America said Owens&Minor’s decision to terminate its planned acquisition of Rotech Healthcare was unexpected but may ultimately prove beneficial, allowing the company to refocus on its core operations and potential asset sales.
investing.com·5mo ago

Latest OMI News

View

Advertisement|Remove ads.

Advertisement|Remove ads.